+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Entecavir"

Entecavir Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Entecavir Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Hepatitis B Virus (HBV) Global Market Report 2024 - Product Thumbnail Image

Hepatitis B Virus (HBV) Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Investigation Report on the Entecavir Market in China 2020-2024 - Product Thumbnail Image

Investigation Report on the Entecavir Market in China 2020-2024

  • Report
  • September 2020
  • 50 Pages
  • China
From
Investigation Report on China Entecavir 2018-2022 - Product Thumbnail Image

Investigation Report on China Entecavir 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
From
Global Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Entecavir is an antiviral drug used to treat chronic hepatitis B virus (HBV) infection. It is a nucleoside analogue, which works by blocking the activity of the virus in the body. Entecavir is used to reduce the amount of virus in the body, reduce the risk of liver damage, and improve liver function. It is also used to reduce the risk of cirrhosis, liver cancer, and death from liver disease. Entecavir is available in both oral and intravenous formulations. Entecavir is a widely used drug for the treatment of chronic HBV infection. It is generally well tolerated and has been shown to be effective in reducing the amount of virus in the body and improving liver function. Entecavir is also used in combination with other drugs to treat more severe cases of HBV infection. Entecavir is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Merck, and Gilead Sciences. Other companies that market entecavir include Mylan, Teva Pharmaceuticals, and Cipla. Show Less Read more